Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cytek Biosciences, Inc. (CTKB : NSDQ)

• Company Description    Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif. Number of Employees: 648

• Price / Volume Information    Yesterday's Closing Price: $3.55 Daily Weekly Monthly 20 Day Moving Average: 1,608,803 shares Shares Outstanding: 126.66 (millions) Market Capitalization: $449.64 (millions) Beta: 1.26 52 Week High: $7.63 52 Week Low: $2.37 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 28.16% 22.73% 12 Week -4.31% -21.35% Year To Date -45.30% -47.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 47215 Lakeview Blvd. - Fremont,CA 94538 USA ph: 877-922-9835 fax: - investors@cytekbio.com https://cytekbio.com

• General Corporate Information    Officers Wenbin Jiang - President; Chief Executive Officer and Director William McCombe - Chief Financial Officer Ming Yan - Chief Technology Officer and Director Jack Ball - Director Don Hardison - Director Peer Information Cytek Biosciences, Inc. (CORR.) Cytek Biosciences, Inc. (RSPI) Cytek Biosciences, Inc. (CGXP) Cytek Biosciences, Inc. (BGEN) Cytek Biosciences, Inc. (GTBP) Cytek Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 23285D109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/05/25 Share - Related Items Shares Outstanding: 126.66 Most Recent Split Date: (:1) Beta: 1.26 Market Capitalization: $449.64 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.24 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.19 Price/Cash Flow: 102.30 Price / Sales: 2.28 EPS Growth vs. Year Ago Period: -80.00% vs. Previous Quarter: -228.57% Sales Growth vs. Year Ago Period: -7.59% vs. Previous Quarter: -27.87% ROE 03/31/25 - -2.90 12/31/24 - -1.54 09/30/24 - -2.58 ROA 03/31/25 - -2.30 12/31/24 - -1.22 09/30/24 - -2.05 Current Ratio 03/31/25 - 5.62 12/31/24 - 5.86 09/30/24 - 6.21 Quick Ratio 03/31/25 - 4.95 12/31/24 - 5.21 09/30/24 - 5.47 Operating Margin 03/31/25 - -5.71 12/31/24 - -3.00 09/30/24 - -5.01 Net Margin 03/31/25 - -5.71 12/31/24 - -3.00 09/30/24 - -5.05 Pre-Tax Margin 03/31/25 - -4.05 12/31/24 - -2.84 09/30/24 - -5.92 Book Value 03/31/25 - 2.98 12/31/24 - 3.07 09/30/24 - 2.93 Inventory Turnover 03/31/25 - 1.91 12/31/24 - 1.83 09/30/24 - 1.71 Debt-to-Equity 03/31/25 - 0.00 12/31/24 - 0.00 09/30/24 - 0.00 Debt-to-Capital 03/31/25 - 0.24 12/31/24 - 0.26 09/30/24 - 0.32

Powered by Zacks Investment Research ©